-
Estimating the Mean Time in Treatment-Free Remission for Patients in Early Line CML
Sep 9, 2025, 16:22 PM -
Clinical Outcomes Associated With Pembrolizumab Immunotherapy in Mesothelioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
AI in Pragmatic Literature Reviews: A Scoping Review of Current Guidance and Development of a Framework for Integration
Sep 9, 2025, 16:22 PM -
Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective
Sep 9, 2025, 16:22 PM -
The Mediating Role of Insomnia in the Relationship Between Disease Severity and Mental Health Quality of Life and Productivity in Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States
Sep 9, 2025, 16:22 PM -
Addressing Payer Concerns: Opportunities for HEOR in Orphan Drug Development
Sep 9, 2025, 16:22 PM -
Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy
Sep 9, 2025, 16:22 PM -
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need
Sep 9, 2025, 16:22 PM -
Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework
Sep 9, 2025, 16:22 PM -
Why TSD26 Matters: How Accurate Was Clinical Expert Opinion in Estimating Long-Term Outcomes?
Sep 9, 2025, 16:22 PM -
Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 2014-2023
Sep 9, 2025, 16:22 PM -
Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Sep 9, 2025, 16:22 PM -
Cost of Treatment of Metastatic Non-Small Lung Cancer in Sweden, 2011-2023
Sep 9, 2025, 16:22 PM -
The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia
Sep 9, 2025, 16:22 PM -
Bimekizumab Demonstrated Sustained Long-Term Improvements in Health-Related Quality of Life and Work Productivity in Patients With Active Psoriatic Arthritis: 3-Year Results from Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
Feasibility of Indication-Specific Pricing for Life Cycle Management of an Innovative Rare Disease Product
Sep 9, 2025, 16:22 PM -
Diagnostic Odyssey of Patients With the Rare Immunodeficiency-Activated PI3 Kinase Delta Syndrome (APDS): Case Study With Expert Interviews and Patient Surveys
Sep 9, 2025, 16:22 PM -
Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia
Sep 9, 2025, 16:22 PM
